Barriers to accrue to clinical trials and possible solutions.
作者信息
Winters Z E, Griffin C, Horne R, Bidad N, McCulloch P
机构信息
Breast Cancer Surgery Patient Reported and Clinical Outcomes Research Group, School of Clinical Sciences, University of Bristol and North Bristol NHS Trust, Bristol, UK.
The Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU), Division of Clinical Studies, Institute of Cancer Research, London, UK.
出版信息
Br J Cancer. 2014 Aug 12;111(4):637-9. doi: 10.1038/bjc.2014.318. Epub 2014 Jun 24.
Abstract
摘要
相似文献
1
Barriers to accrue to clinical trials and possible solutions.临床试验累积的障碍及可能的解决方案。
Br J Cancer. 2014 Aug 12;111(4):637-9. doi: 10.1038/bjc.2014.318. Epub 2014 Jun 24.
2
Why did the study fail?这项研究为何失败？
Eur J Cancer. 2005 Dec;41(18):2784-6. doi: 10.1016/j.ejca.2005.08.024. Epub 2005 Oct 25.
3
Conservative local treatment versus mastectomy after induction chemotherapy in locally advanced breast cancer: a randomised phase III study (EORTC 10974/22002, LAMANOMA)--why did this study fail?局部晚期乳腺癌诱导化疗后保守局部治疗与乳房切除术的比较：一项随机III期研究（EORTC 10974/22002，LAMANOMA）——这项研究为何失败？
Eur J Cancer. 2005 Dec;41(18):2787-8. doi: 10.1016/j.ejca.2005.06.027. Epub 2005 Nov 7.
4
The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.医生对原发性可手术乳腺癌患者纳入随机临床试验的影响。
Breast. 2005 Aug;14(4):310-6. doi: 10.1016/j.breast.2005.01.004.
5
Postmastectomy radiotherapy: quality counts!乳房切除术后放疗：质量至关重要！
J Natl Cancer Inst. 2006 Jan 4;98(1):3-4. doi: 10.1093/jnci/djj008.
6
Direct-to-Implant Extracellular Matrix Hammock-based Breast Reconstruction; Prepectoral or Subpectoral?直接植人物外基质吊床式乳房重建：胸肌前还是胸肌下？
Trials. 2020 Feb 10;21(1):160. doi: 10.1186/s13063-020-4125-6.
7
Review confirms lumpectomy as safe as mastectomy.综述证实保乳手术与乳房切除术同样安全。
BMJ. 1995 Dec 2;311(7018):1451-2. doi: 10.1136/bmj.311.7018.1451a.
8
Breast reconstruction after breast-cancer surgery.乳腺癌手术后的乳房重建。
N Engl J Med. 2009 Jan 22;360(4):419; author reply 420-1.
9
Patient-Centered Breast Reconstruction Based on Health-Related Quality-of-Life Evidence.基于健康相关生活质量证据的以患者为中心的乳房重建
Clin Plast Surg. 2018 Jan;45(1):137-143. doi: 10.1016/j.cps.2017.08.011. Epub 2017 Sep 29.
10
More questions about the European Organisation for Research and Treatment of Cancer 22881-10882 boost trial.关于欧洲癌症研究与治疗组织22881-10882增强试验的更多问题。
J Clin Oncol. 2011 Mar 10;29(8):e212; author reply e213. doi: 10.1200/JCO.2010.30.7785. Epub 2011 Jan 24.
引用本文的文献
1
Predicting the frequencies of drug side effects.预测药物副作用的发生率。
Nat Commun. 2020 Sep 11;11(1):4575. doi: 10.1038/s41467-020-18305-y.
2
A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation.一种用于急诊科临床试验资格筛选的实时自动患者筛查系统：设计与评估
JMIR Med Inform. 2019 Jul 24;7(3):e14185. doi: 10.2196/14185.
本文引用的文献
1
Role of acellular dermal matrix-assisted implants in breast reconstruction.脱细胞真皮基质辅助植入物在乳房重建中的作用。
Br J Surg. 2014 Apr;101(5):444-5. doi: 10.1002/bjs.9415. Epub 2014 Feb 24.
2
Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial).剖腹术后使用切口边缘保护装置对手术部位感染的影响：多中心随机对照试验（ROSSINI 试验）。
BMJ. 2013 Jul 31;347:f4305. doi: 10.1136/bmj.f4305.
3
Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment.即刻背阔肌皮瓣乳房再造及辅助治疗后患者报告结局与关键临床结局的整合。
Br J Surg. 2013 Jan;100(2):240-51. doi: 10.1002/bjs.8959. Epub 2012 Nov 22.
4
The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial.脱细胞真皮基质在两阶段扩张器/植入物重建中的应用：一项多中心、盲法、随机对照试验。
Plast Reconstr Surg. 2012 Nov;130(5 Suppl 2):57S-66S. doi: 10.1097/PRS.0b013e31825f05b4.
5
Guidelines should reflect all knowledge, not just clinical trials.指南应反映所有知识，而不仅仅是临床试验。
BMJ. 2012 Oct 5;345:e6702. doi: 10.1136/bmj.e6702.
6
Randomized clinical trial on the effect of fibrin sealant on latissimus dorsi donor-site seroma formation after breast reconstruction.随机临床试验研究纤维蛋白胶对乳房重建后背阔肌供区血清肿形成的影响。
Br J Surg. 2012 Oct;99(10):1381-8. doi: 10.1002/bjs.8874.
7
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups.在美国肿瘤协作组的 III 期临床试验中达到足够的累积量来解决主要终点。
Clin Cancer Res. 2012 Jan 1;18(1):256-62. doi: 10.1158/1078-0432.CCR-11-1633. Epub 2011 Oct 5.
8
A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life.基于患者报告的结局测量和健康相关生活质量的临床证据系统评价，以指导乳房重建的治疗建议。
Ann Surg. 2010 Dec;252(6):929-42. doi: 10.1097/SLA.0b013e3181e623db.
9
Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design.重新思考实用随机对照试验：引入“队列多重随机对照试验”设计。
BMJ. 2010 Mar 19;340:c1066. doi: 10.1136/bmj.c1066.
10
No surgical innovation without evaluation: the IDEAL recommendations.未经评估，不得进行手术创新：IDEAL 建议
Lancet. 2009 Sep 26;374(9695):1105-12. doi: 10.1016/S0140-6736(09)61116-8.
Zotero 插件